The relationship of the ACCP/SCCM consensus conference classification of sepsis to mortality and multiorgan dysfunction among medial ICU patients

Journal of Intensive Care Medicine

Volumn 11, Issue 6, 1996, Pages 326-334

  Kollef, Marin H ^a   Eisenberg, Paul R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SEPTIC SHOCK;

EID: 0029799389     PISSN: 08850666     EISSN: None     Source Type: Journal    
DOI: 10.1177/088506669601100604     Document Type: Article

References (34)

1. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-1477
2. Bone RC. Sepsis syndrome: new insights into its pathogenesis and treatment. Infect Dis Clin North Am 1991;5:793-805
3. Bone RC. Sepsis, the sepsis syndrome, multiorgan failure: a plea for comparable definitions. Ann Intern Med 1991;114:332-333
4. Eidelman LA, Sprung CL. Why have new effective therapies for sepsis not been developed? Crit Care Med 1994; 22:1330-1334
5. Abraham E, Raffin TA. Sepsis therapy trials: continued disappointment or reason for hope? JAMA 1994;271:1876-1878
6. Wenzel RP. Anti-endotoxin monoclonal antibodies: a second look. N Engl J Med 1992;326:1151-1153
7. Fink MP. Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infections. Crit Care Med 1995;23:989-991
8. Stone R. Search for sepsis drugs goes on despite past failures. Science 1994;264:365-367
9. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Chest 1992;101:1644-1655
10. Knaus WA, Draper KA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829
11. Rubin DB, Wiener-Kronish JP, Murray JF, et al. Elevated Von Willebrand factor antigen is an early phase predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990;86:474-480
12. Hosmer DW, Lemeshow S. Applied logistic regression, ed 1. New York, NY: a Wiley Interscience, 1989:25-81
13. SAS/STAT User's Guide, vol 2. Cary, NC: SAS Institute Inc., 1990:1071-1126
14. Polissar L, Diehr P. Regression analysis in health services research: the use of dummy variables. Med Care 1982; 20:959-966
15. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariahle models. Ann Intern Med 1993; 118:201-210
16. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36
17. Kollef MH, Schuster DP. Predicting intensive care unit outcome with scoring systems: underlying concepts and principles. Crit Care Clin 1994;10:1-18
18. Montaner JS, Hawley PH, Ronco JJ, et al. Multisystem organ failure predicts mortality of ICU patients with acute respiratory failure secondary to AIDS-related PCP. Chest 1992; 102:1823-1828
19. Knaus WA, Wagner DP. Multiple systems organ failure: epidemiology and prognosis. Crit Care Clin 1989;5:221-232
20. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:485-489
21. Kollef MH, Wragge T, Pasque C. Determinants of mortality and multiorgan dysfunction in cardiac surgery patients requiring prolonged mechanical ventilation. Chest 1995; 107:1395-1401
22. Balk RA, Bone RC. The septic syndrome: definition and clinical implications. Crit Care Clin 1989;5:1-8
23. Bone RC. Sepsis, sepsis syndrome, and the systemic inflammatory response syndrome (SIRS). JAMA 1995;273:155-156
24. Knaus WA, Harrel FE, Fisher CJ Jr, et al. The clinical evaluation of new drugs for sepsis: a prospective study design based on survival analysis. JAMA 1993;270:1233-1241
25. Rangel-Frausto MS, Pittet O, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-123
26. Abraham E, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. JAMA 1995;273:934-941
27. Bell RC, Coalson JJ, Smith JD, Johanson WG Jr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983;99:293-298
28. Fisher CJ Jr, Opal SM, Dhainaut J-F, et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 1993;21:318-327
29. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 1995;274:968-974
30. Le Gall J-R, Lemeshow S, Leleu G, et al. Customized probability models for early severe sepsis in adult intensive care patients. JAMA 1995;273:644-650
31. Knaus WA, Sun X, Nystrom PO, Wagner DP. Evaluation of definition of sepsis. Chest 1992;101:1656-1662
32. Lemeshow S, Klar J, Le Gall J-R, Teres D. Customized probability models for severe sepsis: correction and clarification. JAMA 1995;274:872-873
33. Kollef MH. Ventilator-associated pneumonia: a multivariate analysis. JAMA 1993;270:1965-1970
34. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-590